Floatz logo

277 assets in Small Cell Lung Carcinoma

Therapeutic assets addressing Small Cell Lung Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Ide-161
Small Cell Lung Carcinoma
IDEAYA BiosciencesP1CC (43)
lb2102
Small Cell Lung Carcinoma
Legend Biotech USA IncP1CC (43)
ML261
Small Cell Lung Carcinoma
Moonlight Bio, IncP1CC (43)
Obinutuzumab
Small Cell Lung Carcinoma
Chugai PharmaceuticalP1CC (43)
ryz101
Small Cell Lung Carcinoma
RayzeBio, Inc.P1CC (43)
Tazemetostat Hydrobromide
Small Cell Lung Carcinoma
National Cancer Institute (NCI)P1CC (43)
Α-Pd-L1/4-1Bb Dll3 Car-T
Small Cell Lung Carcinoma
Sichuan UniversityP1CC (43)
Nogapendekin Alfa Inbakicept
Small Cell Lung Carcinoma
ImmunityBio, Inc.P2CC (42)
111in-etn029
Small Cell Lung Carcinoma
Novartis PharmaceuticalsP1CC (41)
225ac-etn029
Small Cell Lung Carcinoma
Novartis PharmaceuticalsP1CC (41)
Allopurinol
Small Cell Lung Carcinoma
Washington University School of MedicineP1CC (41)
Anti-Pd-L1 Monoclonal Antibody Ck-301
Small Cell Lung Carcinoma
Checkpoint Therapeutics, Inc.P1CC (41)
dc05f01
Small Cell Lung Carcinoma
Heronova PharmaceuticalsP1/2CC (41)
Dsp-0390
Small Cell Lung Carcinoma
Washington University School of MedicineP1CC (41)
dxc006
Small Cell Lung Carcinoma
Hangzhou DAC Biotechnology Co., Ltd.P1/2CC (41)
exs74539
Small Cell Lung Carcinoma
Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.P1CC (41)
GD2-SADA
Small Cell Lung Carcinoma
Y-mAbs TherapeuticsP1CC (41)
Gocatamig
Small Cell Lung Carcinoma
Merck Sharp & Dohme LLCP1/2CC (41)
Gotistobart
Small Cell Lung Carcinoma
OncoC4, Inc.P1/2CC (41)
her2bbζ/cd19t+ t cells
Small Cell Lung Carcinoma
Shanghai Public Health Clinical CenterP1/2CC (41)
hh160
Small Cell Lung Carcinoma
Huahui HealthP1CC (41)
hlx3901
Small Cell Lung Carcinoma
Shanghai Henlius BiotechP1CC (41)
ibi115
Small Cell Lung Carcinoma
Innovent Biologics (Suzhou) Co. Ltd.P1CC (41)
Itraconazole
Small Cell Lung Carcinoma
PfizerP1CC (41)
ly4175408
Small Cell Lung Carcinoma
Eli Lilly and CompanyP1CC (41)
Mevrometostat
Small Cell Lung Carcinoma
PfizerP1CC (41)
MGC026
Small Cell Lung Carcinoma
MacroGenicsP1CC (41)
neo212
Small Cell Lung Carcinoma
Neonc Technologies, Inc.P1/2CC (41)
nkt3447
Small Cell Lung Carcinoma
NiKang Therapeutics, Inc.P1CC (41)
nn3201
Small Cell Lung Carcinoma
Novelty Nobility, Inc.P1CC (41)
pf-08046050
Small Cell Lung Carcinoma
Seagen, a wholly owned subsidiary of PfizerP1CC (41)
Pimitespib
Small Cell Lung Carcinoma
Brown UniversityP1CC (41)
Rezatapopt
Small Cell Lung Carcinoma
PMV Pharmaceuticals, IncP1/2CC (41)
sc0245
Small Cell Lung Carcinoma
Biocity Biopharmaceutics Co., Ltd.P1/2CC (41)
SC16.56
Small Cell Lung Carcinoma
Memorial Sloan Kettering Cancer CenterP1/2CC (41)
Slv-154
Small Cell Lung Carcinoma
Solve TherapeuticsP1CC (41)
<Sup>177</Sup>Lu-Dota
Small Cell Lung Carcinoma
Y-mAbs TherapeuticsP1CC (41)
sys6010
Small Cell Lung Carcinoma
Shanghai JMT-Bio Inc.P1/2CC (41)
SYS6090
Small Cell Lung Carcinoma
Shanghai JMT-Bio Inc.P1/2CC (41)
TH19P01-DOCETAXEL
Small Cell Lung Carcinoma
TheratechnologiesP1CC (41)
The-0504
Small Cell Lung Carcinoma
Thena Biotech S.r.l.P1CC (41)
Valemetostat
Small Cell Lung Carcinoma
Memorial Sloan Kettering Cancer CenterP1CC (41)
zg005
Small Cell Lung Carcinoma
Suzhou Zelgen Biopharmaceuticals Co.,LtdP1/2CC (41)
ro7616789
Small Cell Lung Carcinoma
Hoffmann-La RocheP1CC (40)
Tocilizumab
Small Cell Lung Carcinoma
Hoffmann-La RocheP1CC (40)
Zeluvalimab
Small Cell Lung Carcinoma
AmgenP1CC (40)
177lu-rad204
Small Cell Lung Carcinoma
Radiopharm Theranostics, LtdEarly P1C (39)
212-lead pentixather
Small Cell Lung Carcinoma
Yusuf MendaEarly P1C (39)
Boclatixafortide
Small Cell Lung Carcinoma
Institut Cancerologie de l'OuestEarly P1C (39)
Debio 0123
Small Cell Lung Carcinoma
Debiopharm International SAP1C (39)
Showing 201 to 250 of 277 assets
PreviousPage 5 of 6Next